Skip to content

Integrative-Interpersonal Dynamic Therapy for Post Stroke Depression: INID-PILOT

Integrative-Interpersonal Dynamic Therapy for Post Stroke Depression: INID-PILOT - INID-Pilot

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
DRKS
Registry ID
DRKS00030378
Enrollment
36
Registered
2023-06-01
Start date
2023-08-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression according to DSM-5 I61 I63 F32

Interventions

Group 1: Patients receive up to 16 sessions of psychotherapy over the course of 12 weeks. This new intervention is a short-term integrative-interpersonal-dynamic psychotherapy for stroke patients. Gr

Sponsors

Klinisches Institut für Psychosomatische Medizin und Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Occurrence of ischemic stroke (ICD-Code: I.63) and intracerebral hemorrhage (I.61) in patients admitted to the two participating Stroke Units Düsseldorf and Heidelberg. 2) Sufficient verbal comprehension at baseline (T0) as defined by sum of = 6 points of the shortened Aphasie-Schnell-Test (AST)3) Sufficient German language comprehension for questionnaire completion and participation in psychotherapy. 4) Depression (i.e., a PHQ-9 score = 11) after discharge from inpatient rehabilitation (T1)

Exclusion criteria

Exclusion criteria: 1) patients with transitory ischemic attack (TIA: ICD-Code G.45) 2) Patients with severe intracerebral hemorrhage, requiring neurosurgical treatment shortly after stroke.

Design outcomes

Primary

MeasureTime frame
The primary outcome is 1) RCT recruitment feasibility and 2) intervention acceptability defined as: 1) recruitment rate (i.e., consent to randomization) of >=20% of eligible patients at T1 (i.e., self-reported PHQ >= 11 at the screening after discharge from inpatient rehabilitation 2) Treatment completion (i.e., participation in >=66% of all therapy sessions) of >=70% in the intervention group

Secondary

MeasureTime frame
As secondary outcomes, changes in depression (PHQ-9/HAMD-D) and anxiety (GAD-7) across all follow-ups (T1 and T2) will tested using uni- and multivariate ANOVA with repeated measurements.

Countries

Germany

Contacts

Public ContactUlrike Dinger-Ehrenthal

Klinisches Instituts für Psychosomatische Medizin und Psychotherapie

ulrike.dinger-ehrenthal@med.uni-duesseldorf.de+49 211 81-18338

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 8, 2026